Supplementary Appendix: Efficacy and Safety of the Oral Janus Kinase 1 Inhibitor Povorcitinib in Patients With Extensive Vitiligo in a Phase 2, Randomized, Double-Blinded, Dose-Ranging, Placebo-Controlled Study
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/52jtsjjd24/3
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Appendix for Efficacy and Safety of the Oral Janus Kinase 1 Inhibitor Povorcitinib in Patients With Extensive Vitiligo in a Phase 2, Randomized, Double-Blinded, Dose-Ranging, Placebo-Controlled Study
